New surgery aims to cut cancer risk without hormone loss
NCT ID NCT01608074
Summary
This study is testing a specific, less invasive surgery for women with BRCA gene mutations who are at high risk for ovarian cancer. The surgery removes the ends of the fallopian tubes, where this cancer often starts, while leaving the ovaries intact to preserve natural hormone production. The goal is to see if this procedure can effectively prevent cancer for women who are unwilling or unable to have their ovaries removed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHR-U
Lille, France
-
Centre Antoine Lacassagne
Nice, France
-
Centre Henri Becquerel
Rouen, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Oscar Lambret
Lille, France
-
Clinique du Bois - Bourgogne Center
Lille, France
-
Hospices Civils de Lyon
Lyon, France
-
Hôpital Privé VA
Villeneuve-d'Ascq, France
-
IUCT-O Toulouse
Toulouse, France
-
Institut Bergonié
Bordeaux, France
-
Institut Curie
Paris, France
-
Institut Gustave Roussy
Villejuif, France
-
Institut Paoli Calmettes
Marseille, France
-
Polyclinique du Parc Rambot
Aix-en-Provence, France
Conditions
Explore the condition pages connected to this study.